The looming case is expected to be the most sweeping abortion issue the high court examines since overturning Roe v. Wade, with implications that extend far beyond reproductive health and could impact how a vast array of drugs are approved and regulated. Read more at Politico
If lower court rulings were left in place, they “would impose grave harms on the government, mifepristone’s sponsors, women seeking medication abortions, and the public,” Prelogar added. Among other things, access to the pill by mail — which the FDA formally approved in 2021 — would be curtailed. Read more at NBC News
For each foregone abortion, the researchers estimated an additional 0.8 births—a previously published conversion that accounts for some pregnant people miscarrying. With that conversion, the estimated additional births are then multiplied by state-specific pregnancy-related mortality rates to get the estimated increase in death. Generally, pregnant people living in states with abortion bans are three times … Read more
Supreme Court Issues Stay, At Least Temporarily Blocking Mifepristone Restrictions From Taking Effect The Supreme Court granted the Department of Justice’s emergency request to temporarily halt lower court rulings that would have reimposed restrictions on mifepristone that the Food and Drug Administration (FDA) had lifted in recent years. The stay is in place until 11:59 … Read more
I called Ziegler today, after the Justice Department’s appeal, to get her take on what happens next. She told me that if the conflicting mifepristone rulings make their way to the Supreme Court, which they’re likely to do, it’s worth noting that the Texas decision that would block the abortion medication was “designed to appeal … Read more
The Supreme Court on Monday struck down a federal court ruling upholding the right for a minor to go to court to get permission to undergo an abortion, with Justice Ketanji Brown Jackson penning a solo dissent in the case. Read more at The Hill
